FDA Investigator: Ankur C. Patel

- Ankur C. Patel first started conducting FDA inspections in 2021, with the last inspection in 2024. Over that time, Ankur C. Patel has conducted 28 inspections at 24 companies across 25 sites.

Get Ankur Patel's official FDA inspection documents. Gain valuable insights from their Form 483s and EIRs to ace your next inspection.

Documents

Upon purchase, you will receive an email with a link to immediately download the documents.

FDA 483 Swati Spentose Private Limited, Vapi | 2024

Out-of-stock
Ankur C. Patel
Human Drugs Form 483

FDA 483 Allchem Lifescience Pvt. Ltd, Vadodara | 2024

Out-of-stock
Ankur C. Patel
Human Drugs Form 483

FDA 483 Umedica Laboratories Pvt. Ltd., Vapi | 2024

Out-of-stock
Ankur C. Patel
Human Drugs Form 483

FDA 483 Eisai Company Ltd., Kakamigahara | 2023

Out-of-stock
Ankur C. Patel
Human Drugs Form 483

FDA 483 Linde Gas North Americca LLC, Phillipsburg | 2022

Out-of-stock
Ankur C. Patel
Human Drug Form 483

FDA 483 Vantage Specialty Ingredients, Linden | 2022

Out-of-stock
Ankur C. Patel
Human Drug Form 483

FDA 483 Samjan Group, Inc., East Brunswick | 2022

Out-of-stock
Ankur C. Patel
Human Drug Form 483